302 related articles for article (PubMed ID: 36505062)
1. Inflammation triggered by the NLRP3 inflammasome is a critical driver of diabetic bladder dysfunction.
Hughes FM; Odom MR; Cervantes A; Purves JT
Front Physiol; 2022; 13():920487. PubMed ID: 36505062
[TBL] [Abstract][Full Text] [Related]
2. Diabetic bladder dysfunction progresses from an overactive to an underactive phenotype in a type-1 diabetic mouse model (Akita female mouse) and is dependent on NLRP3.
Hughes FM; Allkanjari A; Odom MR; Jin H; Purves JT
Life Sci; 2022 Jun; 299():120528. PubMed ID: 35381220
[TBL] [Abstract][Full Text] [Related]
3. Male Akita mice develop signs of bladder underactivity independent of NLRP3 as a result of a decrease in neurotransmitter release from efferent neurons.
Hughes FM; Allkanjari A; Odom MR; Mulcrone JE; Jin H; Purves JT
Am J Physiol Renal Physiol; 2023 Jul; 325(1):F61-F72. PubMed ID: 37167271
[TBL] [Abstract][Full Text] [Related]
4. Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches.
Ram C; Jha AK; Ghosh A; Gairola S; Syed AM; Murty US; Naidu VGM; Sahu BD
Eur J Pharmacol; 2020 Oct; 885():173503. PubMed ID: 32858047
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 Promotes Diabetic Bladder Dysfunction and Changes in Symptom-Specific Bladder Innervation.
Hughes FM; Hirshman NA; Inouye BM; Jin H; Stanton EW; Yun CE; Davis LG; Routh JC; Purves JT
Diabetes; 2019 Feb; 68(2):430-440. PubMed ID: 30425063
[TBL] [Abstract][Full Text] [Related]
6. Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies.
Yang Y; Jiang G; Huang R; Liu Y; Chang X; Fu S
Biochem Pharmacol; 2023 Jun; 212():115569. PubMed ID: 37100255
[TBL] [Abstract][Full Text] [Related]
7. Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications.
Lu X; Tan Q; Ma J; Zhang J; Yu P
Front Cell Dev Biol; 2021; 9():792401. PubMed ID: 35087834
[TBL] [Abstract][Full Text] [Related]
8. [Role of NLRP3 inflammasome in diabetic neuropathy and prevention and treatment with traditional Chinese medicine].
Feng HY; Ding R; Zhou Q; Wu TC; Li H; Ma XT; Yue RS
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):300-310. PubMed ID: 36725219
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes.
Gora IM; Ciechanowska A; Ladyzynski P
Cells; 2021 Feb; 10(2):. PubMed ID: 33546399
[TBL] [Abstract][Full Text] [Related]
10. The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy.
Williams BM; Cliff CL; Lee K; Squires PE; Hills CE
Front Physiol; 2022; 13():907504. PubMed ID: 35755447
[TBL] [Abstract][Full Text] [Related]
11. Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications.
Sharma A; Tate M; Mathew G; Vince JE; Ritchie RH; de Haan JB
Front Physiol; 2018; 9():114. PubMed ID: 29515457
[TBL] [Abstract][Full Text] [Related]
12. Targeting the NLRP3 Inflammasome in Diabetic Nephropathy.
Yang M; Wang X; Han Y; Li C; Wei L; Yang J; Chen W; Zhu X; Sun L
Curr Med Chem; 2021; 28(42):8810-8824. PubMed ID: 34225600
[TBL] [Abstract][Full Text] [Related]
13. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
[TBL] [Abstract][Full Text] [Related]
14. Targeting NLRP3 Inflammasome in the Treatment Of Diabetes and Diabetic Complications: Role of Natural Compounds from Herbal Medicine.
Bai Y; Mu Q; Bao X; Zuo J; Fang X; Hua J; Zhang D; Jiang G; Li P; Gao S; Zhao D
Aging Dis; 2021 Oct; 12(7):1587-1604. PubMed ID: 34631209
[TBL] [Abstract][Full Text] [Related]
15. Diabetic bladder dysfunction is associated with bladder inflammation triggered through hyperglycemia, not polyuria.
Inouye BM; Hughes FM; Jin H; Lütolf R; Potnis KC; Routh JC; Rouse DC; Foo WC; Purves JT
Res Rep Urol; 2018; 10():219-225. PubMed ID: 30533402
[TBL] [Abstract][Full Text] [Related]
16. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
[TBL] [Abstract][Full Text] [Related]
17. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
18. Detrusor contractility to parasympathetic mediators is differentially altered in the compensated and decompensated states of diabetic bladder dysfunction.
Klee NS; Moreland RS; Kendig DM
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F388-F398. PubMed ID: 31141399
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets.
Raman KS; Matsubara JA
Ocul Immunol Inflamm; 2022 Feb; 30(2):470-478. PubMed ID: 33026924
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis.
Wan Z; Fan Y; Liu X; Xue J; Han Z; Zhu C; Wang X
Diabetes Metab Syndr Obes; 2019; 12():1931-1942. PubMed ID: 31571967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
